e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Brain Metastasis and Malignant pleural effusion: improving our understanding
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The incidence of Malignancy and Survival in Patients with Idiopathic Pleuritis
S. Reuter (Naestved, Denmark), P. Clementsen (Roskilde, Denmark), U. Bodtger (Naestved, Denmark)
Source:
International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Session:
Brain Metastasis and Malignant pleural effusion: improving our understanding
Session type:
Oral Presentation
Number:
3796
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Reuter (Naestved, Denmark), P. Clementsen (Roskilde, Denmark), U. Bodtger (Naestved, Denmark). The incidence of Malignancy and Survival in Patients with Idiopathic Pleuritis. 3796
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Effusions related to TB
Medical thoracoscopy – step by step
Thoracoscopy appearances: similarities and diversities
Related content which might interest you:
Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Prevalence of Eosinophilia in Patients with Tuberculosis
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Chronic granulomatous disease diagnosed in adulthood- Report of 2 Cases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
“A Study of Infective Etiology in Patients With Acute Exacerbation of COPD”
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020
Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020
Plasma derived-exosome microRNAs in Idiopathic Pulmonary Fibrosis of Anti-synthetase syndrome Disease patients
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome
Source: International Congress 2014 – ILDs 1
Year: 2014
Pleural complicationsin patients with chronic and end-stage renal disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Prognostic Factors for Mortality in Chronic Pulmonary Aspergillosis -Experience in Japan-
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept